Predictors of hypoglycemia avoidance in a randomized controlled rtCGM trial (HypoDE)
Hermanns, Norbert; Heinemann, Lutz; Freckmann, Guido; u. a. (2018): Predictors of hypoglycemia avoidance in a randomized controlled rtCGM trial (HypoDE), in: Diabetes, Alexandria, Va: American Diabetes Association, Jg. 67, Nr. Suppl. 1, S. A79 (298-OR), doi: 10.2337/db18-298-OR.
Details
- Fakultät/Lehrstuhl
- Autorin(nen)/Autor(en)
- Heinemann, LutzFreckmann, GuidoWaldenmaier, Delia
- Titel der Zeitschrift
- Diabetes
- ISSN
- 0012-1797
- Herausgebende Institution
- American Diabetes Association
- Verlagsangabe
- American Diabetes Association : Alexandria, Va
- Erscheinungsjahr
- 2018
- Jahrgang
- 67
- Heft
- Suppl. 1
- Sprache(n)
- Englisch
- Anmerkungen
Abstract:
The HypoDE study, a randomized multi-center trial, showed that rtCGM use reduces the number of low glucose events (<55 mg/dl for at least 20 minutes) per 28 days from 10.4 to 3.4 events compared to SMBG (13.5 to 13.2 events) in MDI-treated type 1 diabetic patients with hypoglycemia problems. In this post-hoc analysis, we analyzed which baseline variables predict successful reduction of low glucose events. The criterion was a reduction to 0 events or by 50% from baseline. In a block-wise, multivariate logistic regression, demographic and medical variables, patient-reported-outcomes, biochemical hypoglycemia at baseline (based on 4-week masked rtCGM use), hours per day in time in range and hyperglycemia, and use of rtCGM were used as predictors. Model fit of the block-wise regression suggests that none of the baseline characteristics did predict hypoglycemia avoidance. However, entering use of rtCGM led to a rise of Nagelkerke´s R² from 0.061 to 0.331. This indicates that rtCGM use was the most important predictor for hypoglycemia avoidance. In the CGM Group, 76.1% of the patients compared to 26.3% in the Control group could avoid hypoglycemic events (Odds ratio 9.8, 95% CI 4.2 to 23.0). This suggests that rtCGM use is effective in patients with type 1 diabetes and hypoglycemia problems regardless of diabetes duration, glycemic control, severity of hypoglycemia problems, and exposure to biochemical hypoglycemia at baseline.
- DOI
- URL
- Peer Reviewed
- ja
- Internationale Verbreitung
- ja
- Open-Access-Zeitschrift
- nein
- Dokumenttyp
- Artikel in einer Zeitschrift / Postprint
- URI
- Datum der Freischaltung
- 15.01.2020